Found: 3
Select item for more details and to access through your institution.
Tetrahydrobiopterin (BH<sub>4</sub>): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12312
- By:
- Publication type:
- Article
Post-COVID-19 patients in geriatric rehabilitation substantially recover in daily functioning and quality of life.
- Published in:
- Age & Ageing, 2024, v. 53, n. 5, p. 1, doi. 10.1093/ageing/afae084
- By:
- Publication type:
- Article
Effects of tetrahydrobiopterin oral treatment in hypoxia-induced pulmonary hypertension in rat.
- Published in:
- Pulmonary Circulation, 2014, v. 4, n. 3, p. 462, doi. 10.1086/677361
- By:
- Publication type:
- Article